🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Anlotinib is a novel small molecule multi-target tyrosine kinase inhibitor ...
Status
Unknown
Location
Shandong cancer hospital
Start Date
2019-06-25
Trial ID
NCT04004975
Treatments Being Tested
Abstract Study title: Single-center, Multi-cohort Exploratory Phase Ib/II C...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-01
Trial ID
NCT05608785
Treatments Being Tested
In this study, investigators aimed to evaluated the efficacy and safety of ...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2021-03-05
Trial ID
NCT04665609
Treatments Being Tested
This multicenter observational study aims to evaluate the safety and effica...
Status
Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2025-12-23
Trial ID
NCT07419932
This study is single center single arm prospective phase II study. In this ...
Status
Completed
Location
Samsung Medical Center
Start Date
2017-05-30
Trial ID
NCT03086538
Treatments Being Tested